Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTLI.L Regulatory News (TLI)

  • There is currently no data for TLI

Net Asset Value(s) - Replacement

15 Jul 2013 15:29

RNS Number : 3563J
Alternative Asset Opps PCC Ltd
15 July 2013
 



Alternative Asset Opportunities PCC Limited (the "Company")

 

15 July 2013

 

The following replaces "Net Asset Value(s)" announcement dated Monday 15 July 2013 at 9.54 am under RNS Number 3097J

Net debt at 30 June 2013 should have been announced as US$2,811,000 and not US$3,494,000 as stated. The full correct announcement appears below.

 

 

The Board of Alternative Asset Opportunities PCC Limited (the "Company") announces that the net asset value of the US Traded Life Interests Fund at 30 June 2013 was 55.6 pence per share. This represents a decrease of 1.0 penny per share from the NAV at 31 May 2013. During the month LE adjustments on 5 policies reduced NAV by 0.9 pence per share and a profit equivalent to 0.5 pence per share was recognised from the maturity of one policy on one life with a face value of US$1,000,000.

 

Exchange rate movements had no material impact during the month. The Company's borrowings as at 30 June 2013 stood at US$5,939,000. Net debt, taking into account cash balances and capital debtors (being the above maturity proceeds and one of the two policy maturities announced in the previous month not yet received), amounted to US$2,811,000.

 

The Board has for some time been concerned at the low level of maturities compared to the life expectancy (LE) projections from our panel of assessors. Earlier this year it therefore requested the Investment Manager to resume the programme of obtaining LE updates, covering a significant portion of the portfolio. Given the difficulties in assessing LEs, the Board is also considering the appropriateness of the 12% discount rate (IRR) utilised in its valuation in the light of the higher IRR requirements of policy buyers seen on many transactions during the last 2-3 years. This work, which is likely to result in a modest reduction in reported NAV, is expected to be completed by early September and the Board will advise Shareholders of the outcome, which will be reflected in the audited financial results for the year ended 30 June 2013. The Board already publishes, and will continue to publish, tables which allow investors to assess the effects of differing valuation assumptions on the NAV.

 

The table below aims to give investors an appreciation of the effects on valuation of different assumptions as to both LE and IRR.

 

- The first line of NAVs in the table uses the 'Latest LE' assumption, that is to say either an LE based on a recently updated assessment (obtained on or after 1 January 2011) or, for the remaining 26% of the portfolio by face value (the 'non-updated policies'), either the original LE at the time of purchase or an LE updated before 31 December 2010. The average LE is shown for reference (4.5 years). NAV is then shown at four different discount rates, ranging from 10% to 20%. This shows the effect of IRR on current value, but it also allows investors to assess the effects of forced sales.

- The second line uses the assumption that updated LEs obtained for the non-updated policies would broadly follow those already obtained for other policies, resulting in an LE increase of 10% on the non-updated policies. In practice, the LE changes exhibited by actual revised assessments vary widely and the Board does not feel it is necessarily correct to extrapolate the changes for the non-updated policies. The overall effect is to increase average LE by 0.1 years.

- The third line assumes an increase in LE of 20% on the non-updated policies. The effect on NAV is an incremental increase in LE of 0.2 years.

- Finally, the fourth line shows the outcome of assuming LEs are simply based on the current table of life expectancies for the general population, the 2008 Valuation Basic Table i.e. ignoring medical assessments. The Board does not suggest that this is a realistic assumption, but it gives a measure of the degree to which the portfolio is dependent on assessed LEs being shorter than for the population as a whole.

Sensitivity Matrix

Net Asset Value in pence per share on various assumptions as at 30 June 2013

 

Discount Rates applied to cash flows

Mortality Assumptions

Average LE

10%

Current (12%)

16%

20%

Latest LE

4.5

59.2

55.6

49.4

44.5

+10% for LE dates before 01/01/2011

4.6

57.3

53.7

47.7

42.9

+20% for LE dates before 01/01/2011

4.8

55.6

52.0

46.1

41.4

No underwriting

5.1

51.4

47.7

41.7

36.9

 

 

 

 

Enquiries:

Peter Ingram

Company Secretary

Tel: 020 7065 1467

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVNKPDBQBKDBOD
Date   Source Headline
4th Nov 20149:34 amRNSListing Rule 15.6.8
17th Oct 20149:04 amRNSNet Asset Value(s)
2nd Oct 20143:58 pmRNSHolding(s) in Company
2nd Oct 20141:26 pmRNSListing Rule 15.6.8
23rd Sep 201410:44 amRNSDirector/PDMR Shareholding
15th Sep 201411:51 amRNSDirector/PDMR Shareholding
15th Sep 201411:45 amRNSNet Asset Value(s)
15th Sep 20147:00 amRNSFinal Results
2nd Sep 201411:04 amRNSListing Rule 15.6.8
28th Aug 201411:33 amRNSHolding(s) in Company
28th Aug 201410:30 amRNSHolding(s) in Company
27th Aug 201411:40 amRNSHolding(s) in Company
19th Aug 201410:21 amRNSNet Asset Value(s)
13th Aug 20147:00 amRNSPolicy Maturity
4th Aug 20141:12 pmRNSListing Rule 15.6.8
31st Jul 20143:03 pmRNSHolding(s) in Company
24th Jul 201411:18 amRNSResult of EGM
21st Jul 20149:19 amRNSHolding(s) in Company
17th Jul 20148:52 amRNSNet Asset Value(s)
1st Jul 20144:49 pmRNSListing Rule 15.6.8
20th Jun 201411:44 amRNSProposed conditional return of capital
16th Jun 20149:25 amRNSNet Asset Value(s)
9th Jun 20149:38 amRNSHolding(s) in Company
3rd Jun 20143:30 pmRNSListing Rule 15.6.8
28th May 201411:29 amRNSPolicy Maturity
23rd May 20143:36 pmRNSPolicy Maturity
19th May 20148:51 amRNSNet Asset Value(s)
15th May 20143:19 pmRNSHolding(s) in Company
12th May 20142:20 pmRNSInterim Management Statement
1st May 20143:53 pmRNSListing Rule 15.6.8
22nd Apr 20142:38 pmRNSNet Asset Value(s)
16th Apr 201411:12 amRNSHolding(s) in Company
2nd Apr 20147:00 amRNSLoan Refinancing
18th Mar 201412:56 pmRNSNet Asset Value(s)
14th Mar 201410:10 amRNSHolding(s) in Company
12th Mar 20142:59 pmRNSDirector/PDMR Shareholding
7th Mar 201411:39 amRNSHolding(s) in Company
7th Mar 201411:31 amRNSDirector/PDMR Shareholding
4th Mar 20149:57 amRNSListing Rule 15.6.8
4th Mar 20149:37 amRNSHolding(s) in Company
3rd Mar 20143:14 pmRNSHolding(s) in Company
3rd Mar 201410:37 amRNSDirector/PDMR Shareholding
28th Feb 20141:47 pmRNSHalf Yearly Report
28th Feb 201412:33 pmRNSHolding(s) in Company
18th Feb 20144:26 pmRNSNet Asset Value(s)
5th Feb 20149:59 amRNSListing Rule 15.6.8
15th Jan 20143:29 pmRNSNet Asset Value(s)
3rd Jan 20142:12 pmRNSListing Rule 15.6.8
23rd Dec 20132:42 pmRNSNet Asset Value(s) Replacement
17th Dec 20132:46 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.